NCT07898111
A Study of VAX-ID® 2200, a New Device for Intradermal Injections
StatusEnrolling by Invitation
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
assess whether the injury prevention mechanism of the VAX-ID® 2200 function
Timeframe: 1 year
Arms and interventions
Health professionals
Participants will engage in simulated use testing by executing injections on a 3D-printed patch model after receiving standardized training materials that simulate real-world use conditions. These include the comprehensive Instructions for Use (IFU) and a video presentation. A total of 2 trained observers will record user interactions during the simulated-use injections, assessing all tasks and focusing on critical ones, and will categorize these interactions as success, difficulty encountered, close call incidents, or use errors.
Devices: VAX-ID® 2200
Sites
1 site in 1 country
- Memorial Sloan Kettering Cancer Center (All Protocol Activities)New York, New York, United States